RVMD STOCK ANALYSIS

Revolution Medicines Inc — price, returns and risk statistics

RVMDRevolution Medicines Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel

Price summary

Last Close

189.24 $

Jul 2, 26

Market Cap

37.5 B $

Q1 2026 (TTM)

52-Week Range

34.70 $192.62 $

Return and risk cards

Total Return

%+408.8

Trailing 1-year performance

Volatility

%67.3

Price fluctuation measure

Sharpe Ratio

2.14

Risk/Return ratio

Sortino Ratio

3.44

Downside risk/return

Distance to Peak

%-1.8

Difference from 52-week peak

Maximum Drawdown

-%25.0

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+25.1%

3M

+90.9%

6M

+137.6%

YTD

+137.6%

1Y

+408.8%

3Y

+605.3%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
RVMD+137.6%Gold-3.2%Silver-10.4%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Revolution Medicines Inc (RVMD) stock price?

RVMD last closed at 189.24 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Revolution Medicines Inc?

Revolution Medicines Inc (RVMD) has a market capitalization of approximately 37.5 B $ as of the latest reported period.

Who are the main competitors of RVMD?

Key peers of Revolution Medicines Inc include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.

Go deeper on RVMD

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.